Meeting Background Materials

First Page		Document Content
Denosumab Giant-cell tumor of bone Osteoprotegerin Osteopathies Osteosarcoma Osteoporosis Bone tumor Metastasis RANKL Medicine Oncology Amgen		Meeting Background Materials Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 386,59 KB Share Document on Facebook

	Xgeva (denosumab) tablets DocID: 1gujy - View Document
	Identification of novel molecules that regulate bone homeostasis using ENU-induced mutant mice models Jiake Xu School of Pathology and Laboratory Medicine, The University of Western Australia, Western Australia, Australi DocID: 152v2 - View Document
	The Effects of Raloxifene on Incident Vertebral Fractures in Postmenopausal Women with Osteoporosis: 4-Year Results from the MORE Trial DocID: 14IjE - View Document
	PL-ISSNprint), ISSNonline) Folia Biologica (Kraków), vol), No 2 Ó Institute of Systematics and Evolution of Animals, PAS, Kraków, 2014 DocID: 13E4S - View Document
	Available online http://arthritis-research.com/content/9/S1/S1 Review Biology of RANK, RANKL, and osteoprotegerin Brendan F Boyce and Lianping Xing DocID: 12NCk - View Document